Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study
ConclusionSSRI use was associated with a significant decrease in MACE rates compared with patients receiving mirtazapine. Bleeding risk was not affected by either antidepressant treatment. SSRIs may have cardioprotective benefits compared with mirtazapine.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Cardiovascular | Clopidogrel | Coronary Angioplasty | Depression | Disability | Drugs & Pharmacology | Heart | Heart Attack | Mirtazapine | Percutaneous Coronary Intervention | Plavix | Stroke | Study